NASHVILLE, Tenn. (WZTV) — A Tennessee bill seeking to make cannabis legal for medical purposes is moving forward.
The "Tennessee Medical Cannabis Act" seeks to regulate medical marijuana.
Proposed by State Sen. Janice Bowling (R-Tullahoma) and Rep. Iris Rudder (R-Winchester), SB0854/HB0621 would also allow licenses for providers of medical cannabis which would allow for the cultivation, transportation, transport, and selling to dispensaries.
Among the "qualifying conditions" to use medical cannabis include cancer, glaucoma, epilepsy, HIV/AIDS, Crohn's disease, muscular sclerosis, opioid addiction, renal failure, severe nausea or chronic pain, persistent muscle spasm, PTSD, severe psoriasis, ALS, Parkinson's, and end of life pain management. Scroll down for a full list of medical conditions.
The measure is moving to the Senate Judiciary Committee after the Senate Government Operations Wednesday morning recommended it for passage on Wednesday.
On Tuesday, the Senate Judiciary killed SB 0153, a bill 5-4 legalizing THC levels from legal hemp and CBD products.
Another bill seeks to create a commission to study medical cannabis, but it would only kick in if Congress removes marijuana from controlled substances enforcement. This measure is moving to the Senate Judiciary Committee as well but was not recommended for passage by Senate Government Operations Wednesday.
Medical conditions that this bill would apply to, according to the lawmakers:
- Crohn's disease
- Multiple sclerosis
- Opioid addiction
- Renal failure
- Severe nausea or chronic pain
- Any medical condition producing cachexia, persistent muscle spasm, or seizures
- Post-traumatic stress disorder
- Chronic radiculopathy
- Severe psoriasis
- Post-laminectomy syndrome
- Psoriatic arthritis
- Complex pain syndrome, including trigeminal neuralgia, amyotrophic lateral sclerosis (ALS), and Parkinson's disease
- End-of-life pain management or palliative care
- Traumatic brain injury
- Tourette syndrome
- Autism spectrum disorder
- Sickle cell anemia
- The following conditions if the patient is younger than eighteen (18) years of age:
- Cerebral palsy
- Cystic fibrosis
- Osteogenesis imperfecta; and
- Muscular dystrophy
- Terminal conditions; and
- Any additional conditions approved by the commission pursuant to rulemaking